Kyoto University Innovation Capital Corporation (Head office: Sakyo-ku, Kyoto; Representative Director: Koji Murota; hereinafter "KyotoiCAPInnovation Kyoto, Inc. as an unlimited liability partnership2016Investment Limited Liability Partnership ("theKYOTO–iCAP("No. 1 Fund") is pleased to announce that the U.S.Drawbridge Health Inc.(Headquarters: California, President:Lee MacCrackenHereinafter referred to as "Drawbridge HealthAdditional investment in the "company"),GE Ventures, ,Thorne Research Inc.MitsubishiUFJCapital Corporation and Dainippon Sumitomo Pharma Co.

Drawbridge Healthis a healthcare company that develops medical devices that enable the convenient, automated collection of blood samples for testing and the long-term stable storage of the blood samples at room temperature. This medical device has been shown to reduce the discomfort experienced by individuals undergoing common blood collection methods (venipuncture and finger stick).2The simplicity of the system is expected to make it possible for medical professionals to collect blood anytime, anywhere. The simplicity of operation is also expected to make it possible for healthcare professionals to collect blood anytime, anywhere without the need for special training. In additionDrawbridge HealthThe company is the main result,the 2018 MedTech Breakthrough Awards program 1andAmerican Diabetes Association 2The results were highly acclaimed and presented at the

Drawbridge HealthThe company is collaborating with Professor Nobuya Inagaki and Assistant Professor Kaori Ikeda of the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Hospital, to research and develop the company's blood collection medical technology in Japan. Kyoto, JapaniCAPis due to this capital increase,Drawbridge HealthWe hope that the revolutionary new blood collection technology developed by the company will promote its development in Japan and the rest of the world, and that this blood collection technology will contribute to the health of various people.

Works Cited:
1. https://drawbridgehealth.com/wp-content/uploads/2018/06/MedTech-Breakthrough_2018-Winner-Release_Drawbridge-Health_Final.pdf
2. Innovative Blood Sampling Technology for Convenient, Nearly Painless, and Accurate Monitoring of Diabetes, Elisa Romeo et al. https://diabetes. diabetesjournals.org/content/68/Supplement_1/231-LB

periodDrawbridge Health Inc.About
Drawbridge HealthThe company is,GE VenturesandGE HealthcareA privately held U.S. healthcare technology company founded by Dr. David H. Harris, Ph. The company integrates proprietary engineering and chemical technologies to develop medical devices that reduce discomfort during blood collection and preserve blood stably after collection, with the goal of creating a world in which a variety of personal diagnostics are possible anytime, anywhere. For more information,Home Pagefor more information.